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Abstract
Summary Because osteoporosis is under-recognized in patients with vertebral fractures, we evaluated characteristics associated with osteoporosis identification. Most patients with vertebral fractures did not receive evaluation or treatment for
osteoporosis. Black, younger, and male participants were particularly unlikely to have had recognized osteoporosis, which
could increase their risk of negative outcomes.
Introduction Vertebral fractures may be identified on imaging but fail to prompt evaluation for osteoporosis. Our objective was to evaluate characteristics associated with clinical osteoporosis recognition in patients who had vertebral fractures
detected on their thoracolumbar spine imaging reports.
Methods We prospectively identified individuals who received imaging of the lower spine at primary care clinics in 4 large
healthcare systems who were eligible for osteoporosis screening and lacked indications of osteoporosis diagnoses or treatments in the prior year. We evaluated characteristics of participants with identified vertebral fractures that were associated
with recognition of osteoporosis (diagnosis code in the health record; receipt of bone mineral density scans; and/or prescriptions for anti-osteoporotic medications). We used mixed models to estimate adjusted odds ratios (ORs) and 95% confidence
intervals (95% CIs).
Results A total of 114,005 participants (47% female; mean age 65 (interquartile range: 57–72) years) were evaluated. Of the
8579 (7%) participants with vertebral fractures identified, 3784 (44%) had recognition of osteoporosis within the subsequent
year. In adjusted regressions, Black participants (OR (95% CI): 0.74 (0.57, 0.97)), younger participants (age 50–60: 0.48
(0.42, 0.54); age 61–64: 0.70 (0.60, 0.81)), and males (0.39 (0.35, 0.43)) were less likely to have recognized osteoporosis
compared to white participants, adults aged 65 + years, or females.
Conclusion Individuals with identified vertebral fractures commonly did not have recognition of osteoporosis within a year,
particularly those who were younger, Black, or male. Providers and healthcare systems should consider efforts to improve
evaluation of osteoporosis in patients with vertebral fractures.
Keywords Age · Gender · Osteoporosis · race · Thoracolumbar imaging · Vertebral fracture
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Introduction

Patients and methods

Osteoporosis is a progressive disease of low bone mass
and bone architecture deterioration that increases fracture
risk. It is a growing societal problem, affecting over 10%
of people over age 50 [1]. Having one or more osteoporotic vertebral fractures is strongly predictive of subsequent
osteoporotic fractures, especially hip fractures [2]. Furthermore, patients with osteoporotic vertebral fractures are
at increased risk of death relative to non-fractured populations, particularly in the months immediately after the
fracture [3], and the increased mortality rate persists for at
least the next 10 years [4].
Because bone demineralization causes no symptoms,
many patients do not realize they have osteoporosis until
significant, symptomatic fractures occur. Early identification of diminishing bone mass can help prevent more severe
skeletal injuries. Screening with bone mineral densitometry
(BMD) such as dual energy X-ray absorption (DEXA) scans
in appropriate age groups can identify individuals with low
bone mass and prompt treatment with anti-osteoporotic medications. However, most people at risk for osteoporosis are
not screened; a recent study estimated that less than 25% of
women age 65 + underwent bone mass measurements over a
2-year study period [5]. Additionally, even though the presence of a vertebral fracture is an indication to strongly consider pharmacotherapy for osteoporosis regardless of BMD
[6, 7], recognition/reporting of vertebral fractures on imaging is lacking, particularly when fractures are not present
in the areas of the spine that led to the image being ordered
[8, 9]. A recent audit of computed tomography (CT) scans
performed for reasons other than trauma found that only 60%
of vertebral fractures were identified when present and only
2.6% of the patients with vertebral fractures were referred
for further treatment [10]. A similar study conducted in Germany found that 30% of patients who had received CT scans
mainly for cancer staging and angiography CT imaging had
prevalent vertebral fractures, but only a quarter of the fractured patients’ imaging reports mentioned the fractures [11].
Our objective was to evaluate the frequency with which
vertebral fractures identified on thoracolumbar imaging
reports were followed by electronic health record (EHR)based evidence that patients were evaluated for osteoporosis.
We also sought to describe demographic and clinical characteristics associated with osteoporosis assessment, hypothesizing that females and older individuals with vertebral
fractures would be most likely to have had osteoporosis that
was recognized. A secondary aim was to examine participant and clinical characteristics that were associated with
the likelihood of osteoporosis recognition in those without
identified vertebral fractures on their thoracolumbar imaging
reports to determine whether the same associations existed.

Study population

13

This study was registered at ClinicalTrials.gov identifier:
NCT02015455.
The parent study for these secondary analyses was the
Lumbar Imaging with Reporting of Epidemiology (LIRE)
study, which has been described previously [12, 13]. We
randomly assigned 98 adult primary care clinics within
four health systems [Mayo Clinic (Rochester, MN); Henry
Ford (Detroit, MI); Kaiser Permanente Northern California
(Oakland, CA); and Kaiser Permanente Washington (Seattle, WA)] to insert text with the epidemiologic benchmark
prevalence of common imaging findings among individuals
without back pain [13–15] into imaging reports. We automatically enrolled participants ≥ 18 years old who received
thoracolumbar spine imaging from October 2013 to September 2016, who had no spine imaging in the past year, and had
not opted out of research studies.
For this secondary analysis, we limited the sample to
those who were potentially eligible for osteoporotic screening according to guidelines from the National Osteoporosis Foundation (NOF) and who lacked indications of
osteoporosis being recognized in the EHR prior to receiving their index spine images. Therefore, we included men
who were ≥ 50 years because that was the youngest age that
guidelines began to recommend men be screened, if they
had additional risk factors [16]. We included women who
were ≥ 52 years because the NOF, among others [16], recommends screening postmenopausal women and the average age at which women become postmenopausal is 52 [17,
18]. We excluded those who had (1) International Classification of Diseases, 9th and 10th Revisions, Clinical Modification (ICD-9-CM and ICD-10-CM) codes indicating cancer,
osteoporosis, and/or osteopenia (Supplemental Table 1); (2)
received BMD scans; and (3) been prescribed osteoporotic medications (Supplemental Table 2) in the year prior to
their index thoracolumbar spine images. We also would have
excluded participants whose index images were due to acute
severe trauma (defined as having had CT scans of ≥ 3 of the
following regions: head, chest, abdomen, pelvis, or spine) but
did not identify any. We identified participants with vertebral
fractures described on their X-ray, magnetic resonance imaging (MRI), or CT scan index imaging reports using an adaptation of a previously validated natural language processing
(NLP) methodology [19]. The rules-based algorithm required
keywords related to both “spine” AND “fracture” as well
as morphologies that could represent fractures (Supplemental Table 3). The algorithm was validated in a sample with
all four sites represented of N = 100 reports using 2 annotators and 1 adjudicator and was found to have a sensitivity of
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96%, specificity of 99%, positive predictive value of 90%, and
negative predictive value of 99.7% for identifying vertebral
fractures on thoracolumbar imaging reports.

Exposure and outcome variables
We obtained participant characteristics from the EHR and
included age (categorized as 50–60, 61–64; 65 + years),
sex, imaging modality (X-ray, CT, or MRI), race/ethnicity
(mutually exclusive categories included Asian, Black/African American, Native Hawaiian/Pacific Islander, multiracial, Native American/Alaska Native, white, Hispanic (of
any race), and unknown), calendar time of the index image
(categorized in 6-month intervals), Charlson comorbidity
index category (0, 1, 2, and ≥ 3) [20], and participant socioeconomic status (SES). To estimate SES, the study sites
mapped participant addresses to Federal Information Processing System codes using geocoding software, which were
then mapped to SES indexes derived from the 2010 Census
Summary File and the American Community Survey data
[21] and categorized into quartiles that were created from
this national data [22].
The outcome of interest was evidence in the EHR that
clinicians considered the need for evaluation of osteoporosis. We defined this as presence in the EHR from the day of
the index image through 365 days later of (1) ICD-9-CM
or ICD-10-CM diagnosis codes indicating osteoporosis or
osteopenia (see Supplemental Table 1 for codes); (2) written prescription for ≥ 1 anti-osteoporotic medication (Supplemental Table 2); or (3) procedure codes indicating BMD
scans (Supplemental Table 1). We investigated this outcome
in the cohort of participants who did and did not have vertebral fractures identified on their index imaging reports.

Statistical analysis
We evaluated numbers and percentages for categorical variables and means, medians, and interquartile ranges (IQRs)
for continuous variables for the characteristics of participants who did and did not have vertebral fractures identified
on their index imaging reports.
We used mixed models (which account for the fact that
participants within providers and/or clinics would have been
expected to have had correlated osteoporosis recognition
patterns) to estimate adjusted odds ratios (ORs) and 95%
confidence intervals (95% CIs) for indications of recognition
of osteoporosis in the EHR. We included all variables in the
same models but separately modeled the cohort that did have
vertebral fractures identified on their index imaging reports
from the cohort that did not. We also adjusted all models for
the participant’s health care system and whether the image
occurred during the control (i.e., no benchmark text present
on the imaging report) or intervention (i.e., benchmark text

present on the imaging report) period. We used SAS 9.4
(Cary, NC) for all analyses and two-sided p values < 0.05
were considered significant.

Results
Of the 238,886 participants who were enrolled in the LIRE
parent study, 114,055 met our inclusion criteria (Fig. 1). Of
these, 8579 (8%) were identified to have vertebral fractures
on their index imaging reports. In the subsequent 12 months,
3784 (44%) had received ≥ 1 ICD-9-CM or ICD-10-CM
osteoporosis diagnosis code, BMD scans, and/or prescriptions for anti-osteoporotic medications. Among the 105,426
participants who were not identified as having vertebral
fractures on their index imaging reports, 13,893 (13%) had
osteoporosis recognized within a year (Fig. 1).
About one-fifth of participants with identified vertebral
fractures received BMD scans within 12 months of the index
image (n = 1662; 19%) (Fig. 2) and most (n = 1556; 94%) of
these had osteoporosis diagnosis codes in their EHRs. However, only 724 participants (8.4%) of those with identified
vertebral fractures on their index imaging reports received
prescriptions for anti-osteoporotic medications. Of those
without identified vertebral fractures on their index imaging reports whose osteoporosis was clinically recognized,
n = 5587 (5%) received BMD scans within a year and 998
(0.9%) received prescriptions for anti-osteoporotic medications within a year (Fig. 3).
Characteristics of the cohort, stratified by whether vertebral fractures were identified on index imaging reports,
are shown in Table 1. Participants with identified vertebral fractures were older than those who were not identified as having fractures (mean (IQR) of 70.3 (61–68)
versus 64.9 (57–71) years) and were less likely to have
been female (47% of participants with identified vertebral fractures were female compared to 53% of those
without identified vertebral fractures). Participants with
identified vertebral fractures were more likely to have had
X-rays as the index imaging modality (87% versus 79%)
and 72% of participants with identified vertebral fractures
were white, compared to 64% of those without identified
vertebral fractures. Participants with identified vertebral
fractures were likely to have more comorbid conditions
(12% of participants with identified vertebral fractures had
3 + comorbid conditions versus 7% of participants without
identified vertebral fractures).
Results of adjusted models examining the odds of recognition of osteoporosis among participants with identified
vertebral fractures are shown in Table 2. We excluded those
with missing SES data from multivariate models (n = 3197
(2.8%)). Younger participants were less likely to have had
osteoporosis documented in their health records compared
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Fig. 1  Flow of participants for analysis
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Fig. 2  Proportions of participants with vertebral fractures identified on their index imaging reports who received bone mineral density scans,
osteoporosis diagnoses, and anti-osteoporotic medications within 1 year

Fig. 3  Proportions of participants without vertebral fractures identified on their index imaging reports who received bone mineral density scans,
osteoporosis diagnoses, and anti-osteoporotic medications within 1 year

to older participants (compared to age 65 + , age 50–60 OR
(95% CI): 0.48 (0.42, 0.54); age 61–64 0.70 (0.60, 0.81)).
Compared with females, males (0.39 (0.35, 0.43)) were
less likely to have had recognized osteoporosis, as were

participants who received CT (0.24 (0.11–0.50)) or magnetic resonance imaging (MRI) (0.39 (0.34, 0.46)) compared with X-rays. Participants who identified as Black
were also less likely to have had documented osteoporosis
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Table 1  Characteristics of participants with and without vertebral fractures identified on their index imaging reports who met inclusion criteria
N (column %) or mean (median) interquartile range

Vertebral fracture identified on index imag- No vertebral fracture identified on
ing report (n = 8579)
index imaging report (n = 105,426)

Age (years)
Age category
50–60
61–64
65 +
Female
Type of imaging
X-ray
Computed tomography
Magnetic resonance imaging
Race/ethnicitya
Asian
Black/African American
Native Hawaiian/Other Pacific Islander
Native American/Alaska Native
Multiracial
White
Hispanic
Unknown
Time period
Oct 2013–Mar 2014
Apr 2014–Sept 2014
Oct 2014–Mar 2015
Apr 2015–Sept 2015
Oct 2015–Mar 2016
Apr 2016–Sept 2016
Charlson comorbidity index
0
1
2
3+
Socioeconomic status
Lowest
Low medium
High medium
Highest
Missing
Study site
Kaiser Permanente: Washington
Kaiser Permanente: Northern California
Henry Ford
Mayo Clinic

70.3 (70) 61–80

64.9 (63) 57–71

1998 (23)
1003 (12)
5578 (65)
4024 (47)

41,074 (39)
16,045 (15)
48,307 (46)
55,992 (53)

7480 (87)
63 (1)
1036 (12)

83,743 (79)
469 (0.4)
21,214 (20)

836 (10)
454 (5)
37 (0.4)
50 (0.6)
18 (0.2)
6140 (72)
884 (10)
160 (2)

10,042 (10)
10,753 (10)
504 (0.5)
581 (0.6)
268 (0.3)
67,953 (64)
13,004 (12)
2321 (2)

1907 (22)
1135 (13)
1470 (17)
1410 (16)
1276 (15)
1381 (16)

20,640 (20)
13,409 (13)
16,919 (16)
18,551 (18)
17,481 (17)
18,426 (17)

4633 (54)
1785 (21)
1122 (13)
1039 (12)

65,482 (62)
21,179 (20)
10,945 (10)
7820 (7)

495 (6)
1035 (12)
1931 (23)
4875 (57)
243 (3)

6500 (6)
12,865 (12)
24,229 (23)
58,878 (56)
2954 (3)

535 (6)
7058 (82)
645 (8)
341 (4)

6915 (7)
86,121 (82)
7038 (7)
5352 (5)

a

Categories are mutually exclusive. Hispanic category includes Hispanic ethnicity with any race

relative to those who identified as white (0.74 (0.57, 0.97)).
We did not observe significant associations between SES
or Charlson comorbidity score and the likelihood of EHR
osteoporosis recognition.
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Multivariable results were similar when we examined
participants who did not have identified vertebral fractures
on their index imaging reports (Table 3). Younger participants, males, participants who received MRI, and those who
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Table 2  Results of mixed
effects model for osteoporosis
recognition among participants
with vertebral fractures
identified on their index
imaging reports

Variable

Adjusteda odds ratio
(95% confidence
interval)

Age 50–60 vs 65 +
Age 61–64 vs 65 +
Participant male vs female
Computed tomography vs X-ray
Magnetic resonance imaging vs X-ray
Asian vs white
Black vs white
Hawaiian/Pac. Islander vs white
Native American/Alaskan vs white
Multiracial vs white
Hispanic vs white
Unknown race/ethnicity vs white
Lowest SES vs highest SES
Low-medium SES vs highest SES
High-medium SES vs highest SES
Charlson 1 vs Charlson 0
Charlson 2 vs Charlson 0
Charlson 3 vs Charlson 0
Time April 2014–September 2014 vs October 2013–March 2014
Time October 2014–March 2015 vs October 2013–March 2014
Time April 2015–Sept 2015 vs October 2013–March 2014
Time October 2015–Mar 2016 vs October 2013–March 2014
Time April 2016–Sept 2016 vs October 2013–March 2014

0.48 (0.42–0.54)
0.70 (0.60–0.81)
0.39 (0.35–0.43)
0.24 (0.11–0.50)
0.39 (0.34–0.46)
1.09 (0.88–1.34)
0.74 (0.57–0.97)
0.79 (0.38–1.64)
1.48 (0.80–2.75)
0.18 (0.02–1.43)
1.31 (0.90–1.89)
0.93 (0.79–1.08)
0.94 (0.76–1.17)
0.97 (0.83–1.13)
0.90 (0.80–1.02)
1.05 (0.93–1.19)
1.13 (0.98–1.31)
1.06 (0.92–1.24)
1.00 (0.85–1.18)
1.05 (0.89–1.24)
0.70 (0.58–0.84)
1.03 (0.84–1.25)
0.90 (0.72–1.12)

a

All variables included in same model, which included random effects for index imaging clinic and image
ordering provider. Model was additionally adjusted for study site and whether the intervention text was
included in their index imaging reports
Abbreviation: SES socioeconomic status

identified as Black were less likely to have had documented
osteoporosis relative to those who were older, female,
received X-rays, and were white. Participants who identified as Asian were more likely to have had recognized osteoporosis compared to white participants (1.20 (1.10, 1.31)).
People with more comorbidities were also more likely to
have had osteoporosis documented compared to people who
did not have any comorbidities.

Discussion
Among participants whose imaging reports indicated they
had vertebral fractures, the majority did not have evidence in
the EHR that clinicians considered the need for evaluation of
osteoporosis within a year. Only 8% of participants with fractures identified on their imaging reports had EHR evidence
of initiating anti-osteoporotic medications. Even among participants whose osteoporosis was recognized in the EHR,
only half received prescriptions for anti-osteoporotic medications or received BMD scans. The main characteristics that

were associated with lack of recognition of osteoporosis were
receiving MRI or CT, male sex, younger age, and identifying
as Black. The last three characteristics are all associated with
a lower risk of osteoporosis in the general population and
clinicians may be biased into discounting the likelihood of
osteoporosis in these participants even in the presence of vertebral fractures. Our findings indicate that more direct, less
nuanced approaches to alerting clinicians about the possible
presence of osteoporosis are needed. These could include
machine learning clinical decision support algorithms or
radiologists specifically mentioning the presence of vertebral fractures and the need for osteoporosis evaluation in the
impression section of imaging reports. These simple steps
could improve the recognition and treatment of osteoporosis
in patients who are less commonly diagnosed with osteoporosis but remain at risk.
Guidelines from the National Osteoporosis Foundation
and Osteoporosis Canada state that patients with histories
of spine fractures should receive pharmacologic treatment because vertebral fractures greatly increase the risk
of morbidity and mortality [6, 17] as well as increase the
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Table 3  Results of mixed
effects model for osteoporosis
recognition among participants
without vertebral fractures
identified on their index
imaging reports

Variable

Adjusteda odds ratio
(95% confidence
interval)

Age 50–60 vs 65 +
Age 61–64 vs 65 +
Participant male vs female
Computed tomography vs X-ray
Magnetic resonance imaging vs X-ray
Asian vs white
Black vs white
Hawaiian/Pac. Islander vs white
Native American/Alaskan vs white
Multiracial vs white
Hispanic vs white
Unknown race/ethnicity vs white
Lowest SES vs highest SES
Low-medium SES vs highest SES
High-medium SES vs highest SES
Charlson 1 vs Charlson 0
Charlson 2 vs Charlson 0
Charlson 3 vs Charlson 0
Time April 2014–September 2014 vs October 2013–March 2014
Time October 2014–March 2015 vs October 2013–March 2014
Time April 2015–Sept 2015 vs October 2013–March 2014
Time October 2015–Mar 2016 vs October 2013–March 2014
Time April 2016–Sept 2016 vs October 2013–March 2014

0.24 (0.23–0.25)
0.54 (0.51–0.57)
0.23 (0.22–0.24)
0.76 (0.56–1.03)
0.65 (0.62–0.69)
1.20 (1.10–1.31)
0.70 (0.63–0.76)
0.94 (0.69–1.29)
1.07 (0.82–1.40)
1.10 (0.72–1.69)
0.98 (0.84–1.14)
1.08 (1.01–1.15)
0.92 (0.84–1.01)
0.98 (0.92–1.05)
1.02 (0.97–1.07)
1.05 (1.01–1.11)
1.09 (1.02–1.16)
1.25 (1.16–1.34)
0.96 (0.89–1.03)
0.98 (0.91–1.05)
0.83 (0.77–0.90)
1.00 (0.91–1.08)
1.05 (0.96–1.15)

a

All variables included in same model, which included random effects for index imaging clinic and image
ordering provider. Model was additionally adjusted for study site and whether the intervention text was
included in their index imaging reports
Abbreviation: SES socioeconomic status

likelihood of subsequent future fractures [2]. Osteoporosis screening and treatment are vastly underutilized in
populations at risk of fragility fractures as well as those
who have sustained fractures already [23, 24]. Previous
studies have documented that Black patients were less
likely to receive BMD scans or treatment for osteoporosis compared to white patients [25–27]. Similarly, men
have been shown to be dramatically less likely to receive
BMD screening [28–30] or anti-osteoporotic medications
than women, even after adjustment for future hip fracture
risk (OR = 0.08 (0.06–0.10)) [25]. Like our study, prior
research has shown that patients age < 65 years are less
likely than those age 65–74 years to receive BMD scans
[27]. Some research has indicated that the likelihood of
being treated for osteoporosis among eligible patients
has declined over calendar time [31, 32], but we did not
observe significant associations with time period and the
odds of osteoporosis recognition in the EHR, perhaps
because our study took place over only 2.5 years.
We found that participants whose index imaging modality
was MRI or CT were less likely to have had indications of
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osteoporosis recognition in their EHRs compared to participants who received X-rays. We speculate that providers
who were concerned that their patients’ back pain was due to
osteoporotic vertebral fractures may have been more likely
to have ordered X-rays than other imaging modalities and
thus were also more likely to have recognized the vertebral
fractures when they received the imaging reports. Also, participants who received MRI/CT may have had conditions
that were more serious than participants whose index images
were X-rays, and these other diagnoses took attention away
from osteoporosis.
We found similar risk factors for unrecognized osteoporosis among participants without identified vertebral fractures
on their index imaging reports as among those with identified vertebral fractures. One difference was that participants
with more comorbid conditions who did not have identified
vertebral fractures on index were more likely to have had
documented osteoporosis. Possibly this is because some
comorbidities are associated with increased likelihood of
having osteoporosis, including hyperthyroidism, rheumatoid
arthritis, and chronic pulmonary disease [33]. Furthermore,
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patients with more comorbid conditions may be less able to
engage in physical activity which would put them at greater
risk of developing osteoporosis [34]. Also, patients with
more comorbidities have been shown to have more interactions with their providers [35], so it is likely that they had
more opportunities for osteoporosis to be noted.
Another difference comparing participants without identified
vertebral fractures on their index imaging reports to those with
identified vertebral fractures was that participants who identified
as Asian were more likely to have had recognized osteoporosis
in their EHRs compared to whites. Compared to non-Hispanic
white individuals, some studies have indicated Asian-Americans
have lower BMDs [36–38], but Asian individuals have been
documented as having lower rates of osteoporotic fractures compared to non-Hispanic white individuals [38, 39]. A recent study
conducted in Hawaii found no difference in the likelihood of
receiving osteoporosis treatment among Asian-Americans compared to individuals who identified as white or Native Hawaiian/
Pacific Islander following adjustment for demographic variables
[40]. Further research on associations between racial groups and
osteoporotic treatment is needed.
A major strength of our study is the large sample size.
Limitations include potential errors in the ascertainment of
vertebral fractures on the index images, since we relied on the
reports of the imaging studies rather than the actual images. In
fact, it is possible that this reliance on imaging reports rather
than images resulted in underestimating the vertebral fractures
in this population, since vertebral fractures are often not commented upon in imaging reports [10, 11]; it is also possible
that vertebral fractures were identified when they were not
actually present. We also did not have information about the
methods, whether qualitative, quantitative, or simply intuition, that the radiologists used to determine whether vertebral
fractures were present. Also, we did not have information for
each of the 98 primary care clinics included in our analyses on
whether specialists who performed osteoporosis consultations
were available onsite or nearby. It is possibly that the presence of such specialists could have affected how readily osteoporosis was recognized. Furthermore, we assumed that the
majority of vertebral fractures identified by NLP were osteoporotic because we excluded many non-osteoporotic causes
of vertebral fractures such as cancer and severe trauma, but it
is possible that some of the identified fractures were not due
to osteoporosis and thus osteoporosis was appropriately not
clinically recognized. Our study was also limited by our ability to determine whether osteoporosis was recognized using
EHR data. For example, we would not have detected whether
participants saw providers who diagnosed osteoporosis,
ordered BMD scans, or prescribed anti-osteoporotic medications at facilities outside of their healthcare systems, and those
would have been misclassified as not having had recognized
osteoporosis. However, participants have financial incentive
to receive care from within these systems so presumably we

captured most healthcare utilization. In addition, our finding
that most participants with identified vertebral fractures did
not receive prescriptions for anti-osteoporotic medications
may have been for appropriate reasons, such as the presence
of contraindications, that we were unable to account for in
these analyses, but we do not expect contraindications would
have applied to most of the participants who were eligible for
anti-osteoporotic medications in our sample. We were also
unable to account for participants’ preferences. A recent survey of postmenopausal women who had recently been diagnosed with osteoporosis found that 65% of the patients chose
not to initiate pharmacological treatment because they were
concerned about side effects [41]. By definition, patients in
our analysis cohort could not have had spine imaging or osteoporosis diagnoses in the year prior to index, but we did not
have data from more than 1 year prior to index and thus we
were unable to adjust our analyses for whether patients had
had previous osteoporotic fractures, an important predictor of
future osteoporotic fractures.
We found that participants with vertebral fractures identified on imaging reports often did not have clinically recognized osteoporosis within a year and those who were
younger, identified as Black, or male were less likely than
those who were older, white, or female to have had their
osteoporosis recognized. Our findings suggest that clinicians
could heighten their awareness of imaging reports that indicate vertebral fractures and health systems could consider
implementing automated interventions that would decrease
the impact of clinician bias in the recognition of vertebral
fractures and osteoporosis.
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